Our Leadership Team and Board

More Than a Decade of Experience in Health Care Business Intelligence

We provide vital services to many of the largest emergency departments in the U.S., spanning the clinical, quality, financial, and operational domains. Meet our leadership team and board of directors behind our powerful performance analytics solutions.

Scott Richards

Founder and Chief Executive Officer

[email protected]973-650-4693

Scott Richards has 30 years of experience in health care as an operations and information technology innovator. Richards’ diverse background in health care spans accounting, consulting, project management, information technologies, product development, business process transformation, and operations. He has worked with health care industry stakeholders to identify, plan and implement solutions that transform business operations, enhance patient care, and launch new initiatives.

SEE MORE

As d2i’s CEO, Richards focuses on product strategy, business development, sales and marketing, business administration, and corporate and services infrastructure. He also participates in client relationship management.

Before launching d2i, he was the President and COO of a multi-site retail clinic company he incubated and spun off from its parent company. He served as the Chief Transformation Officer and CIO of a $120 million diversified, multi-entity health care specialty provider and services organization; Director of University Health System’s $1.2 billion Information Services Division; principal in a health care informatics consulting firm he co-founded; and Director of Operations for a health care information systems company.

Jonathan Rothman

Founder and Chief Solutions Officer

[email protected]973-919-4464

Jonathan Rothman has over 27 years of hands-on experience developing operational and business intelligence (BI) solutions for health care companies; with 20 years dedicated to Emergency Medicine. Rothman’s diverse background in health care includes insurance underwriting, managed care contracting, physician and hospital billing, and IT system selection, implementation, and support. He has been published in numerous books and articles on health care BI and has won or been nominated for national awards in the area of BI innovation specific to Emergency Medicine. Rothman received his MBA in Risk Management and a B.S. in Finance from Temple University.

SEE MORE

As d2i’s CTO, Rothman focuses on product strategy, architecture, and development, as well as new site startup, ongoing support, and client relationship management.

Rothman was previously the Director of Data Management for a $120 million diversified, multi-entity health care specialty provider, where he architected and managed its business intelligence solution.

Alan Eisman

Executive Vice President, Business Development

[email protected]646-831-0641

Alan Eisman has more than 30 years of experience in enterprise software, including in ERP, CRM, performance management, analytics, data management, and health care information technology.

SEE MORE

He has a deep passion for igniting and leading change, especially in health care, where there’s an urgent need to move from fragmented care to integrated, value-based care. Eisman has worked closely with many health systems, including Mount Sinai Health, Northwell Health, NYU Langone, and St Luke’s, advising them on a broad range of data and analytics initiatives targeted toward financial, operations, and clinical performance improvement.

As d2i’s executive vice president of business development, Eisman is responsible for growth strategy, product messaging and positioning, and sales and marketing execution.

Before joining d2i, he served as senior vice president of sales and marketing at HBI Solutions, a leader in health care machine learning and predictive analytics, and as executive director of health care industry for Information Builders, where he grew health and life sciences industry revenues by more than 500 percent. Eisman, who received his initial training in information systems at IBM, has led high-growth teams at six software companies, including both early-stage and large, global firms.

Board of Directors

Howard Goldstein

Managing Partner of Cortlandt Private Capital d2i Investment Group’s Board Representative

Howard Goldstein is Managing Partner of Cortlandt Private Capital, which advises and invests in small- to medium-sized companies in the areas of consumer, retail distribution, restaurants and food service, health and wellness, computer software and hardware, telecom, internet, healthcare services, biotech, and medical devices. He is also a Co-Founder and an Operating Partner of Vedanta Capital, a diversified venture capital investment firm. Before that Goldstein worked for 22 years as a General Partner of Invesco Private Capital (and its predecessor firms), a global private equity manager with more than $2 billion in managed assets. He is a seasoned venture capitalist with more than three decades of investment experience.

SEE MORE

Goldstein has been very involved with community service. He is a Board Member and wish granter mentor of the Make-a-Wish Foundation of the Hudson Valley. He and his wife Neva were recipients of the chapter’s Chris Greicius Award in 2012. He is also a member of the Audit and Finance Committee of the National Board of the Make-a-Wish Foundation of America and Board Member and Vice President of the H.O.P.E. For Youth Foundation. Goldstein has also served as a board member of the New York-Presbyterian/Hudson Valley Hospital Center.

Mark Taffet

CEO & Founder Mast Advisors, Inc.

With over twenty years of experience as a corporate finance advisor and operating executive, Mr. Taffet sets the practical, hands-on tone characteristic of Mast Advisors, Inc. During his career, Mr. Taffet has represented domestic and international companies in strategic transactions including acquisitions, divestitures, corporate sales, joint ventures, strategic investments, private equity and debt placements, and management buy-outs. His clients include larger companies with middle-market transaction needs, and public and private middle-market companies.

SEE MORE

Before founding Mast Advisors, Taffet held positions with Shearson, Oppenheimer, American Corporate Services, KPMG, and most recently, Fieldstone Private Capital Group. Taffet served as President and Co-Founder of BayMark Capital, an investment bank formed in a strategic alliance with KPMG. Taffet also served as Executive Vice President and Chief Operating Officer of Globe Foodservices Corporation, a New York area institutional foodservice provider.

Taffet received his BA degree from Sarah Lawrence College and his JD degree from Fordham University School of Law, where he was a member of the International Law Journal. Taffet is a member of the New York State Bar Association.

Advisor to the Board

Susan Nedza, MD

Strategic Advisor

Susan Nedza, MD, MBA, MLA, FACEP is a nationally recognized emergency physician leader who is board-certified in emergency medicine and clinical informatics. Dr. Nedza’s expertise is in the areas of health information technology, advanced payment models, performance measurement, and Medicare/Medicaid policy.

SEE MORE

Dr. Nedza serves as a strategic advisor to d2i and supports product development that will enhance the ability of clients to capture, visualize, analyze and act upon data that supports successful performance in alternative payment models.

Dr. Nedza has served as a Chief Medical Officer for Region V of the Centers for Medicare and Medicaid Services (CMS), Senior Executive at the American Medical Association (AMA), and as a Health Information Technology Executive at Healthy Circles, LLC. Most recently, she served as the primary investigator in the successful design of the Acute Unscheduled Care Model (AUCM) on behalf of the American College of Emergency Physicians. This alternative payment model has been referred by the Secretary of Health and Human Services (HHS) to CMS for integration into alternative payment models. Dr. Nedza is an Adjunct Assistant Professor at the Feinberg School of Medicine of Northwestern University.

Ross Martinson

Martinson Ventures, President Edison Partners, General Partner

Ross Martinson is a director of six Martinson Ventures companies, providing software and information services. He evaluates investment opportunities and assists in due diligence. Martinson coordinates closings and leads exits for Martinson Ventures.

SEE MORE

Martinson is a General Partner for three current Edison Partners funds. He is a director of two Edison portfolio companies. He previously served 15 other Edison companies as a director, including lead director and chairman roles. Martinson focuses on technology-enabled services for business applications and functions. Martinson has participated in many successful company sales.

Mark Rosenberg, DO, MBA, FACEP, FAAHPM, FACHT

Chairman Emeritus, Emergency Medicine

Past President – American College of Emergency Physicians (ACEP)

Dr. Rosenberg is past Chairman of the Geriatric Emergency Medicine Section of the American College of Emergency Medicine (ACEP); Chairman and Founder of the Palliative Medicine Section of ACEP; Board Member of ACEP; and a Board of Director and Past President of NJ chapter of ACEP. Dr. Rosenberg is principal author of the Geriatric Emergency Department Guidelines. He has served as a consultant to NQF regarding Palliative medicine and worked with the American Geriatric Society to promote the Emergency Department as the hub of Geriatric Care. He has written many articles and chapters on Emergency Department Innovations and has lectured internationally. He has developed an acclaimed program called LSMA Life Sustaining Management and Alternatives.

SEE MORE

In 2014, Dr. Rosenberg developed the Emergency Medicine Acute Pain Management Fellowship program, with the first fellow graduating in the spring of 2015. In January 2016, he opened the nation’s first Alternatives to Opioids Program (ALTO). This is a multidisciplinary acute pain management program that not only helps patients without using opioids, but also helps patients with drug dependency and addiction.

Trusted by Your Peers

We transform data for dozens of leading hospitals and health care organizations across the U.S.

Loading...